 LOS ANGELES, Nov. 30, 2020 GLOBE NEWSWIRE -- Glancy Prongay Murray LLP GPM reminds investors of the upcoming December 22, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Innate Pharma SA Innate or the Company NASDAQ: IPHA securities between March 10, 2020 and September 8, 2020, inclusive the Class Period. 